QuantiFERON® SARS-CoV-2 is now CE-marked
Get valuable insights into our immune system’s response to COVID-19
The QuantiFERON® SARS-CoV-2 assay measures T-cell responses to SARS-CoV-2 and aids in the assessment of immunity in individuals who have received COVID-19 vaccination.
COVID-19 vaccines stimulate the body to produce antibodies and activate T-cells to fight a SARS-CoV-2 infection. Serology tests, which measure the antibodies, often generate positive test results after vaccination but are unable to assess cellular responses. The QuantiFERON® SARS-CoV-2 assay detects CD4+ and CD8+ T-cell responses, thereby enabling a much more comprehensive assessment of immunity generated by COVID-19 vaccines.
The assay is based on QIAGEN’s QuantiFERON® interferon gamma release technology – an easy-to-use T-cell assay.